Immediate Pain Relief After Photodynamic Therapy in Oral Candidiasis: A Clinical Trial

Objective: Fungal infection of the oral mucosa that appears in the oral cavity is known as oral candidiasis and the patients experience a fair amount of pain and discomfort. The objective of this article is to evaluate the efficiency of photodynamic therapy (PDT) treatment as a pain management approach in patients with oral candidiasis. Methods: The study was a clinical trial where 20 patients who had oral candidiasis were involved. Participants were randomly assigned to two groups: the PDT group (n=10) or the placebo group (n=10). In the PDT group, PDT was done on the lesions of the oral mucosa using a photosensitizer (methylene blue) and red light at wavelengths of 630-660 nm for 5-10 minutes. The placebo group underwent a similar process as the experimental group but did not use the photosensitizing agent and activation light. Pain intensity was measured using a Visual Analog Scale (VAS) at five-time points: baseline (before treatment), immediately post-treatment, and at 30 minutes, 1 hour, and 2 hours post-treatment. The first study variable was the VAS scores at different post-treatment intervals compared to baseline readings. Results: At baseline, the mean VAS scores were comparable between the PDT group (7.5 ± 1.2) and the placebo group (7.6 ± 1.1). Immediately post-treatment, the PDT group reported a significant reduction in pain (4.2 ± 1.5) compared to the placebo group (7.3 ± 1.2), with a p-value of <0.001. This significant difference in pain relief persisted at all subsequent time points: 30 minutes (3.8 ± 1.6 vs. 7.0 ± 1.3, p<0.001), 1 hour (3.5 ± 1.7 vs. 6.8 ± 1.4, p<0.001), and 2 hours (3.2 ± 1.8 vs. 6.5 ± 1.5, p<0.001) post-treatment. Conclusion: This research also established that PDT does provide significant enhancements in the initial reduction of pain in oral candidiasis patients. Therefore, PDT can be a safe and efficient non-surgical approach to managing oral candidiasis, offering prompt relief from pain and enhancing the patient’s quality of life. Further studies with relatively larger sample sizes and longer follow-up periods should be done to substantiate these observations and assess PDT's effects on oral candidiasis in the long run.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-12
DOI
https://doi.org/10.5281/zenodo.14987907
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immediate Pain Relief After Photodynamic Therapy in Oral Candidiasis: A Clinical Trial

Zenodo (CERN European Organization for Nuclear Research)
Photodynamic Therapy Research Studies
article

Immediate Pain Relief After Photodynamic Therapy in Oral Candidiasis: A Clinical Trial

article en

Abstract

Objective: Fungal infection of the oral mucosa that appears in the oral cavity is known as oral candidiasis and the patients experience a fair amount of pain and discomfort. The objective of this article is to evaluate the efficiency of photodynamic therapy (PDT) treatment as a pain management approach in patients with oral candidiasis. Methods: The study was a clinical trial where 20 patients who had oral candidiasis were involved. Participants were randomly assigned to two groups: the PDT group (n=10) or the placebo group (n=10). In the PDT group, PDT was done on the lesions of the oral mucosa using a photosensitizer (methylene blue) and red light at wavelengths of 630-660 nm for 5-10 minutes. The placebo group underwent a similar process as the experimental group but did not use the photosensitizing agent and activation light. Pain intensity was measured using a Visual Analog Scale (VAS) at five-time points: baseline (before treatment), immediately post-treatment, and at 30 minutes, 1 hour, and 2 hours post-treatment. The first study variable was the VAS scores at different post-treatment intervals compared to baseline readings. Results: At baseline, the mean VAS scores were comparable between the PDT group (7.5 ± 1.2) and the placebo group (7.6 ± 1.1). Immediately post-treatment, the PDT group reported a significant reduction in pain (4.2 ± 1.5) compared to the placebo group (7.3 ± 1.2), with a p-value of <0.001. This significant difference in pain relief persisted at all subsequent time points: 30 minutes (3.8 ± 1.6 vs. 7.0 ± 1.3, p<0.001), 1 hour (3.5 ± 1.7 vs. 6.8 ± 1.4, p<0.001), and 2 hours (3.2 ± 1.8 vs. 6.5 ± 1.5, p<0.001) post-treatment. Conclusion: This research also established that PDT does provide significant enhancements in the initial reduction of pain in oral candidiasis patients. Therefore, PDT can be a safe and efficient non-surgical approach to managing oral candidiasis, offering prompt relief from pain and enhancing the patient’s quality of life. Further studies with relatively larger sample sizes and longer follow-up periods should be done to substantiate these observations and assess PDT's effects on oral candidiasis in the long run.

Zenodo (CERN European Organization for Nuclear Research)
Hamdard University (PK), Dow University of Health Sciences (PK), Kobari General Hospital (JP)
Openalex Percentile: Top 52%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.